HaoYue Capital, established in 2014, is a specialized investment bank dedicated to the healthcare sector in China. The firm focuses on connecting the healthcare and capital markets, offering expertise across various areas including biopharma, medical devices, healthcare services, digital health, and precision medicine. With the largest team of senior investment bankers in China exclusively devoted to healthcare, HaoYue Capital closely monitors market trends and developments within the industry. The firm also publishes weekly updates on healthcare news and insights, along with comprehensive research reports, ensuring clients have access to the most current and relevant information in the healthcare landscape.
Huixin Bio is a researcher and developer of liquid biopsy diagnostic products. It focuses on developing world-leading biomedical technologies and products. It offers an automatic exosome purification system.
Degron Therapeutics
Series A in 2025
Degron Therapeutics is a drug discovery platform focused on developing a new class of targeted protein degradation therapeutics, specifically small molecule molecular glue degrader drugs. The company aims to become a leader in the discovery and development of these innovative medicines, which target disease mechanisms that are often inaccessible to traditional small molecule inhibitors. By leveraging its advanced molecular glue protein degradation platform technology, Degron Therapeutics identifies and validates disease targets while creating novel selective compounds. This approach addresses significant unmet medical needs across various therapeutic areas. The company boasts a team of experienced executives and scientific leaders dedicated to enhancing treatment efficiency through its drug development initiatives.
Chazhongxi
Seed Round in 2023
Chazhongxi is a tea brand operator whose primary activities include purchasing, processing, and developing new tea formulas.
Niu Yuanwai Handmade Dumplings
Seed Round in 2023
Niu Yuanwai Handmade Dumplings is a handmade dumpling brand operator.
Hetian Shuipu Health Tea
Seed Round in 2023
Hetian Shuipu Health Tea is a producer of traditional herbal tea. They offer healthy tea drinks containing medical ingredients, allowing clients to enjoy a healthy tea drink.
RainSure Scientific
Series C in 2022
RainSure Scientific is a medical-based manufacturing company that produces PCR instruments, assays, and healthcare services.
Digital Precision Medical (DPM)
Series B in 2022
DPM Digital Precision Medicine specializes in the development of advanced medical equipment and innovative technology, particularly in the field of intraoperative molecular imaging. The company focuses on creating high-sensitivity and high-definition imaging solutions that enhance surgical navigation during procedures. By prioritizing research and development, DPM Digital Precision Medicine aims to deliver easy-to-operate imaging products that improve the precision and effectiveness of surgical interventions, catering to the needs of medical professionals.
Alit Life Sciences
Series A in 2022
Alit Life Sciences is a supplier of instruments, equipment, and technical services tailored for the life sciences and biotechnology sectors. The company has developed a range of products, including its self-developed Countstar IC1000 cell analyzer, launched in 2011, along with several product series such as Biotech, Altair, Rigel, and Mira. Alit provides a comprehensive suite of laboratory instruments, testing reagents, and production equipment that supports customers from research and development through to production. Additionally, the company acts as a supplier of international biological equipment, ensuring that clients in the biotech and life sciences industries have access to a complete kit of essential supplies.
Baicare
Venture Round in 2022
Baicare is a company focused on enhancing clinical microbiological testing and promoting the appropriate use of antibiotics. Utilizing advanced microfluidic chips and gene detection technology, Baicare offers intelligent automated nucleic acid detection products tailored for clinical hospitals. These products enable rapid and accurate identification of pathogenic bacteria and their drug resistance, assisting healthcare professionals in formulating effective treatment plans while minimizing patient suffering and reducing overall medical costs. The company has experienced significant growth and garnered financial support through initiatives such as the National Science and Technology Major Project. Baicare has applied for over 20 patents related to its technology and has been recognized as a National High-Tech Enterprise, gaining the attention of both medical experts and investors.
KingstronBio
Series C in 2021
KingstronBio specializes in the development and manufacturing of advanced heart valve products for cardiac surgeries. The company offers a comprehensive range of biological heart valves, focusing on minimally invasive solutions that enhance patient outcomes. Utilizing cutting-edge technologies, including anti-calcification, dry presentation, and leaflet thinning, KingstronBio aims to deliver innovative and effective products to the medical community, thereby addressing critical needs in cardiovascular care.
Help Therapeutics
Series C in 2021
Help Therapeutics, founded in 2016, is a global clinical-stage biopharmaceutical company focused on developing innovative cell therapeutics derived from induced pluripotent stem cells (iPSCs) for patients suffering from degenerative diseases. The company aims to establish a State National iPS Cell Bank and is dedicated to creating off-the-shelf cell therapy products that address cardiac failure, oncology, and other degenerative conditions. Help Therapeutics specializes in bioengineered stem cell regeneration products, including disease-specific cardiomyocytes and somatic reprogramming techniques, to support regenerative treatments for a variety of ailments, including those affecting the liver, pancreas, and nerves. With a commitment to delivering safe and effective therapies, Help Therapeutics emphasizes superior development and manufacturing technologies to enhance patient outcomes in regenerative medicine.
Kunya Medical
Series A in 2016
Kunya Medical is a provider of medical equipment management services focused on enhancing the maintenance and operational efficiency of hospital equipment. The company offers comprehensive services, including the maintenance and hosting of hospital imaging and radiation equipment, as well as installation, debugging, and repair of large and medium-sized medical devices. Kunya Medical also supplies spare parts and management software, facilitating improved oversight and longevity of clinical medical equipment for hospitals. By outsourcing these critical functions, Kunya Medical aims to help healthcare facilities optimize their equipment management and extend the lifecycle of their medical assets.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.